The University of Georgia’s research prowess was on display for the 42nd annual meeting of the American Society for Virology, the first time in the society’s history that it met in Athens and one of a handful of times the gathering has been held in the Southeast.
Two University of Georgia researchers have been awarded approximately $770,000 from the Global Health Initiative Technology (GHIT) Fund to develop a new drug to kill the dormant liver stages of Plasmodium vivax, the most widespread of the malaria parasites.
My name is Katie Kollars and I grew up in Statesboro, Georgia. I moved to Athens to earn my BFA in scientific illustration at UGA. During my undergrad, I worked as a lab assistant in the dept. of entomology and realized how much I enjoyed working with insects in the […]
Two UGA researchers are working to make it easier to develop effective treatments for malaria, a disease that sickens millions worldwide and kills hundreds of thousands each year. In tropical climates around the globe, malaria poses a grave risk to already vulnerable populations. In 2019, the World Health Organization estimated […]
Ms. Hughes is the Center for Influenza Disease and Emergence Research (CIDER) coordinator and National Institutes of Health contract coordinator within the Center for Vaccines and Immunology at the College of Veterinary Medicine. She manages the operational activities of the center and is responsible for collecting and organizing required contract […]
January 2021: In September 2020, the College of Veterinary Medicine announced SPARTA (SARS SeroPrevalence and Respiratory Tract Assessment), a study funded by the NIH National Institute of Allergy and Infectious Diseases and the National Cancer Institute. The study’s original purpose was to investigate the human body’s response to infection with […]
Hua Shi is a third-year doctoral candidate in the infectious disease department with a major in comparative biomedical science. She was born and raised in China and got her Bachelor of Science degree at the Central South University in China, majoring in pharmacy. Her laboratory experience as an undergraduate triggered […]
What is your role at the CVM? When did you come to UGA? I am an assistant professor in the Department of Infectious Diseases. My research laboratory is in the Center for Vaccines and Immunology. I joined UGA in August 2017. What is your research focus? My lab studies antibodies, […]
A team of researchers at the University of Georgia College of Veterinary Medicine has developed a COVID-19 vaccine candidate that has proven successful in promoting an immune response in early test models. The team is led by Biao He, the Fred C. Davison Distinguished University Chair in Veterinary Medicine at […]
It has been a little under a month since COVID-19 was first recognized as a pandemic by the World Health Organization. Around the world, people from all walks of life have been asked to adapt to a new lifestyle—one of constant change and social distancing. Despite the upheaval, the University […]
Ted Ross, director of the CVM’s Center for Vaccines and Immunology, and his team have partnered with labs and biotech companies to develop new vaccines that could protect against the novel coronavirus that causes COVID-19. Learn more here.
Two College of Veterinary Medicine units were recently honored at Georgia Bio’s Golden Helix Awards and Annual Gala in Atlanta. The Poultry Diagnostic and Research Center (PDRC) was awarded a Community Award and the Center for Vaccines and Immunology (CVI) received a Deal of the Year Award. The Community Awards […]
Dr. Chet Joyner is a trained immunologist and parasitologist. His research program focuses on understanding the biology of Plasmodium vivax, malaria immunology and pathogenesis, and the biology of B cells and plasma cells. The ultimate goals of his research is to use cutting-edge technologies to help development new treatments and […]
The University of Georgia has signed a contract with the National Institutes of Health for an initial award of $8 million to develop a new, more advanced influenza vaccine designed to protect against multiple strains of influenza virus in a single dose. The total funding could be up to $130 […]
Karen Norris, PhD, received her doctorate in biomedical sciences and microbiology from Wright State University School of Medicine and completed post-doctoral training at The Scripps Research Institute. Dr. Norris was appointed as Assistant Professor in Molecular Genetics and Biochemistry at the University of Pittsburgh, then joined the newly formed Department […]
Jarrod Mousa received his PhD from the University of Florida where he studied the structure and mechanism of multidrug transporters in pathogenic bacteria. He then completed a postdoctoral fellowship at Vanderbilt University in the Vaccine Center where he studied the human antibody response to respiratory syncytial virus. Dr. Mousa joined […]
Whitney Rabacal obtained her Bachelor’s degree from Bowdoin College (Brunswick, ME) in 2006 and then worked as a research assistant at Brigham and Women’s Hospital (Boston, MA) in the laboratory Dr. Vicki Rubin Kelley from 2016-2010, focusing on models of autoimmune kidney disease. In 2016, Dr. Rabacal then received her […]
Mark Tompkins is the Director and Principal Investigator of the Center for Influenza Disease and Emergence Research, a NIAID Center of Excellence in Influenza Research and Response (CEIRR) at the University of Georgia. He received his doctorate in Immunology from Emory University and then studied immune mechanisms of autoimmune diseases […]